Galantamine-d3 (hydrobromide)
|
- $121 - $1550
- Product name: Galantamine-d3 (hydrobromide)
- CAS: 2140262-53-7
- MF: C17H22BrNO3
- MW: 368.27
- EINECS:
- MDL Number:
- Synonyms:Galantamine-d3 (hydrobromide);(4aS,6R,8aS)-3-(methoxy-d3)-11-methyl-4a,5,9,10,11,12-hexahydro-6H-benzo[2,3]benzofuro[4,3-cd]azepin-6-ol,monohydrobromide
4 prices
Selected condition：
Brand
- AK Scientific
- Cayman Chemical
- Medical Isotopes, Inc.
Package
- 500μg
- 1mg
- 5mg
- ManufacturerAK Scientific
- Product number1947EG
- Product description(1S,12S,14R)-4-Methyl-9-(trideuteriomethoxy)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol;hydrobromide
- Packaging1mg
- Price$353
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number26103
- Product descriptionGalantamine-d3 (hydrobromide)
- Packaging500μg
- Price$121
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number26103
- Product descriptionGalantamine-d3 (hydrobromide)
- Packaging1mg
- Price$230
- Updated2024-03-01
- Buy
- ManufacturerMedical Isotopes, Inc.
- Product numberD33993
- Product descriptionGalantamine-d3 Hydrobromide
- Packaging5mg
- Price$1550
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 1947EG | (1S,12S,14R)-4-Methyl-9-(trideuteriomethoxy)-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol;hydrobromide | 1mg | $353 | 2021-12-16 | Buy |
| Cayman Chemical | 26103 | Galantamine-d3 (hydrobromide) | 500μg | $121 | 2024-03-01 | Buy |
| Cayman Chemical | 26103 | Galantamine-d3 (hydrobromide) | 1mg | $230 | 2024-03-01 | Buy |
| Medical Isotopes, Inc. | D33993 | Galantamine-d3 Hydrobromide | 5mg | $1550 | 2021-12-16 | Buy |
Properties
storage temp. :Store at -20°C
solubility :Chloroform: soluble
form :A solid
solubility :Chloroform: soluble
form :A solid
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|